{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T17:09:16Z","timestamp":1792602556145,"version":"4.5.0"},"reference-count":11,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:sec>\n                    <jats:title>Case:<\/jats:title>\n                    <jats:p>A 37-year-old woman presented with a 2-week history of a palpable leg mass. Radiographs revealed a 7-mm focal cortical lytic lesion in the midmedial tibial diaphysis with adjacent soft-tissue component. MRI confirmed soft-tissue mass with cortical erosion. Biopsy established a localized type tenosynovial giant cell tumor (TGCT). En bloc excision of the 3-cm mass was performed. Histopathology confirmed localized type TGCT with cortical erosion. The patient remained asymptomatic at the 1-year follow-up without recurrence.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>This rare presentation with midshaft tibial erosion highlights that TGCT should remain in the differential diagnosis even for apparent primary bone lesions in unusual nonperiarticular locations.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.2106\/jbjs.cc.25.00649","type":"journal-article","created":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T19:01:28Z","timestamp":1772737288000},"update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["Tenosynovial Giant Cell Tumor With Bone Erosion of the Tibial Midshaft"],"prefix":"10.2106","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0009-0003-9904-1303","authenticated-orcid":false,"given":"Dylan J.","family":"Riley","sequence":"first","affiliation":[{"name":"Department of Orthopedic Surgery, Section of Orthopedic Oncology, Rush University Medical Center, Chicago, Illinois"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-1844-0380","authenticated-orcid":false,"given":"Nurudeen","family":"Alli","sequence":"additional","affiliation":[{"name":"Department of Orthopedic Surgery, Section of Orthopedic Oncology, Rush University Medical Center, Chicago, Illinois"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9100-9948","authenticated-orcid":false,"given":"Samuel","family":"Alfonsi","sequence":"additional","affiliation":[{"name":"Department of Orthopedic Surgery, Section of Orthopedic Oncology, Rush University Medical Center, Chicago, Illinois"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6406-1211","authenticated-orcid":false,"given":"Michael","family":"Fice","sequence":"additional","affiliation":[{"name":"Department of Orthopedic Surgery, Section of Orthopedic Oncology, Rush University Medical Center, Chicago, Illinois"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2531-5976","authenticated-orcid":false,"given":"Alan T.","family":"Blank","sequence":"additional","affiliation":[{"name":"Department of Orthopedic Surgery, Section of Orthopedic Oncology, Rush University Medical Center, Chicago, Illinois"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,1]]},"reference":[{"issue":"10","key":"bib1-20260305","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.3390\/medicina60101675","article-title":"Treatment modalities for refractory-recurrent tenosynovial giant cell tumor (TGCT): an update","volume":"60","author":"Dania","year":"2024","journal-title":"Medicina."},{"issue":"4","key":"bib2-20260305","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1007\/BF00243061","article-title":"Giant cell tumor of tendon sheath: spectrum of radiologic findings","volume":"21","author":"Karasick","year":"1992","journal-title":"Skeletal Radiol."},{"issue":"2","key":"bib3-20260305","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1007\/s00330-006-0320-4","article-title":"Giant cell tumors of the tendon sheath may present radiologically as intrinsic osseous lesions","volume":"17","author":"De Schepper","year":"2007","journal-title":"Eur Radiol."},{"issue":"8","key":"bib4-20260305","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1007\/s11547-015-0520-6","article-title":"Giant cell tumour of tendon sheath with bone invasion in extremities: analysis of clinical and imaging findings","volume":"120","author":"Wang","year":"2015","journal-title":"Radiol Med."},{"issue":"9","key":"bib5-20260305","first-page":"e29605","article-title":"Giant cell tumor of extensor tendon sheath in ring finger: a case report","volume":"14","author":"Jadhav","year":"2022","journal-title":"Cureus."},{"issue":"3","key":"bib6-20260305","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1073\/pnas.0507321103","article-title":"A landscape effect in tenosynovial giant-cell tumor from activation of CSF1 expression by a translocation in a minority of tumor cells","volume":"103","author":"West","year":"2006","journal-title":"Proc Natl Acad Sci USA."},{"issue":"6","key":"bib7-20260305","doi-asserted-by":"crossref","first-page":"2800","DOI":"10.3892\/ol.2014.2561","article-title":"Giant cell tumor of the tendon sheath extending around the patellar tendon and invading the knee joint and tibia: a case report","volume":"8","author":"Akahane","year":"2014","journal-title":"Oncol Lett."},{"issue":"3","key":"bib8-20260305","first-page":"Article_15","article-title":"Giant cell tumor of tendon sheath with tarsal bones and intertarsal joint invasion: a case report","volume":"110","author":"He","year":"2020","journal-title":"J Am Podiatric Med Assoc."},{"key":"bib9-20260305","doi-asserted-by":"crossref","first-page":"102491","DOI":"10.1016\/j.ctrv.2022.102491","article-title":"Best clinical management of tenosynovial giant cell tumour (TGCT): a consensus paper from the community of experts","volume":"112","author":"Stacchiotti","year":"2023","journal-title":"Cancer Treat Rev."},{"issue":"10197","key":"bib10-20260305","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/S0140-6736(19)30764-0","article-title":"Pexidartinib versus placebo for advanced tenosynovial giant cell tumour (ENLIVEN): a randomised phase 3 trial","volume":"394","author":"Tap","year":"2019","journal-title":"Lancet (London, England)."},{"issue":"10445","key":"bib11-20260305","doi-asserted-by":"crossref","first-page":"2709","DOI":"10.1016\/S0140-6736(24)00885-7","article-title":"Vimseltinib versus placebo for tenosynovial giant cell tumour (MOTION): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial","volume":"403","author":"Gelderblom","year":"2024","journal-title":"Lancet (London, England)."}],"container-title":["JBJS Case Connector"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.2106\/JBJS.CC.25.00649","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T13:44:56Z","timestamp":1787751896000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.2106\/JBJS.CC.25.00649"}},"subtitle":["A Case Report"],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":11,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.2106\/jbjs.cc.25.00649","relation":{},"ISSN":["2160-3251"],"issn-type":[{"value":"2160-3251","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1]]}}}